Hasnain Faheem 4
4 · Gossamer Bio, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Hasnain Faheem
DirectorPresident & CEO
Transactions
- Award
Common Stock
2025-10-01+437,500→ 557,793 total
Holdings
- 5,408,073(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents performance stock unit award, which will vest in full upon the earlier of (i) the approval of a new drug application for seralutinib or (ii) a change in control, in either case on or prior to the fourth anniversary of the grant date, and subject to the Reporting Person's continuous service to the Issuer.